- Home
- NBIX vs UNM Comparison
NBIX vs UNM Comparison
Compare NBIX & UNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NBIX | UNM |
|---|---|---|
| Founded | 1992 | 1848 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Accident &Health Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 12.4B |
| IPO Year | 1996 | 1986 |
Fundamental Metrics
Financial Performance| Metric | NBIX | UNM |
|---|---|---|
| Price | $155.43 | $74.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 12 |
| Target Price | ★ $173.79 | $94.67 |
| AVG Volume (30 Days) | 969.9K | ★ 1.2M |
| Earning Date | 10-28-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | 4.19 | ★ 5.18 |
| Revenue | $2,682,700,000.00 | ★ $13,068,000,000.00 |
| Revenue This Year | $23.76 | $3.55 |
| Revenue Next Year | $18.01 | $3.06 |
| P/E Ratio | $37.10 | ★ $14.35 |
| Revenue Growth | ★ 19.61 | 2.13 |
| 52 Week Low | $84.23 | $66.81 |
| 52 Week High | $157.67 | $84.48 |
Technical Indicators
Market Signals| Indicator | NBIX | UNM |
|---|---|---|
| Relative Strength Index (RSI) | 64.81 | 43.15 |
| Support Level | $150.26 | $73.03 |
| Resistance Level | $154.35 | $77.30 |
| Average True Range (ATR) | 4.16 | 1.32 |
| MACD | 1.07 | -0.31 |
| Stochastic Oscillator | 93.25 | 26.60 |
Price Performance
Historical ComparisonAbout NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About UNM Unum Group
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.